Trial Outcomes & Findings for Evaluate Patients With Chronic Hepatitis by Three-dimensional Force-controlled Ultrasound Measurement (NCT NCT02784925)

NCT ID: NCT02784925

Last Updated: 2017-06-22

Results Overview

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

30 participants

Primary outcome timeframe

up to 6 months

Results posted on

2017-06-22

Participant Flow

Participant milestones

Participant milestones
Measure
Fatty Liver Subjects
Ultrasound (US) B mode image is an alternative method to measure tissue structure and has proven to be an accurate technique to measure subcutaneous fat thickness. Ultrasound (US) B mode image: Ultrasound (US) B mode image is an alternative method to measure tissue structure and has proven to be an accurate technique to measure subcutaneous fat thickness.
Overall Study
STARTED
30
Overall Study
COMPLETED
30
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Evaluate Patients With Chronic Hepatitis by Three-dimensional Force-controlled Ultrasound Measurement

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Fatty Liver Subjects
n=30 Participants
Ultrasound (US) B mode image is an alternative method to measure tissue structure and has proven to be an accurate technique to measure subcutaneous fat thickness. Ultrasound (US) B mode image: Ultrasound (US) B mode image is an alternative method to measure tissue structure and has proven to be an accurate technique to measure subcutaneous fat thickness.
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
30 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
21 Participants
n=5 Participants
Sex: Female, Male
Male
9 Participants
n=5 Participants

PRIMARY outcome

Timeframe: up to 6 months

Population: fatty liver patients

Outcome measures

Outcome measures
Measure
Fatty Liver Subjects
n=30 Participants
Ultrasound (US) B mode image is an alternative method to measure tissue structure and has proven to be an accurate technique to measure subcutaneous fat thickness. Ultrasound (US) B mode image: Ultrasound (US) B mode image is an alternative method to measure tissue structure and has proven to be an accurate technique to measure subcutaneous fat thickness.
Subcutaneous Fat in Steatosis Patients
female__abdomen
9.54 cm^3
Interval 6.79 to 13.98
Subcutaneous Fat in Steatosis Patients
male__abdomen
10.48 cm^3
Interval 4.65 to 16.81
Subcutaneous Fat in Steatosis Patients
female__front thigh
5.24 cm^3
Interval 3.34 to 11.6
Subcutaneous Fat in Steatosis Patients
male__front thigh
4.09 cm^3
Interval 1.89 to 9.12

Adverse Events

Fatty Liver Subjects

Serious events: 30 serious events
Other events: 30 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Fatty Liver Subjects
n=30 participants at risk
Ultrasound (US) B mode image is an alternative method to measure tissue structure and has proven to be an accurate technique to measure subcutaneous fat thickness.Ultrasound (US) B mode image: Ultrasound (US) B mode image is an alternative method to measure tissue structure and has proven to be an accurate technique to measure subcutaneous fat thickness.
Hepatobiliary disorders
fatty liver
100.0%
30/30 • Number of events 30

Other adverse events

Other adverse events
Measure
Fatty Liver Subjects
n=30 participants at risk
Ultrasound (US) B mode image is an alternative method to measure tissue structure and has proven to be an accurate technique to measure subcutaneous fat thickness.Ultrasound (US) B mode image: Ultrasound (US) B mode image is an alternative method to measure tissue structure and has proven to be an accurate technique to measure subcutaneous fat thickness.
Social circumstances
refuse to have body measurement
100.0%
30/30 • Number of events 30

Additional Information

Ming-Shun Wu

WanFangH

Phone: 88629307930

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place